Business
Vale’s Q1 Profit Slides but Tops Estimates; Launches Big New Buyback Program
Maksym Isachenko/iStock via Getty Images
Vale (NYSE:VALE) +5.4% post-market Wednesday after reporting that Q1 net profit fell nearly 20% from a year ago to $4.45B but it was enough to beat the $4.24B analyst consensus estimate.
Q1 adjusted EBITDA from continuing operations dropped to $6.37B from $8.5B in the year-earlier quarter, and net operating revenues fell 14% Y/Y to $10.8B, as sales of iron ore fines and pellets came in lower because of heavy rainfall in Brazil’s Minas Gerais state.
However, Vale (VALE) approved its biggest-ever stock buyback program of up to 500M common shares, ~10% of its outstanding shares, over the next 18 months.
The move is “a clear sign Vale believes its shares are trading at quite cheap levels,” Alpha Key Capital Management CEO Christian Keleti said.
Vale (VALE) disclosed Q1 production and sales volumes earlier this month that declined due to weather-related problems.
Vale’s (VALE) price return has gained 17% YTD while declining 17% during the past year.
Source: seekingalpha.com
Business
Maersk, MSC to End Global Alliance in Container Shipping Shakeup
Sky_Blue/iStock Unreleased via Getty Images
The world’s two biggest shipping lines – A.P. M?ller-Maersk (OTCPK:AMKBY) (OTCPK:AMKAF) and Mediterranean Shipping Co. – said Wednesday they will end their 2M vessel sharing partnership in 2025, a move S&P Global Platts said will shake up the container shipping market and perhaps trigger a price war.
The decision to wind down the 2M alliance comes as shipowners are dealing with declining cargo volumes and excess vessel capacity that has pushed down freight rates to pre-COVID levels, which has shifted the balance of power back to customers of 2M and other big alliances.
In a joint statement, the chief executives of Maersk (OTCPK:AMKBY) (OTCPK:AMKAF) and MSC said much has changed since the 10-year partnership was signed in 2015, and ending the agreement “paves the way for both companies to continue to pursue their individual strategies.”
Maersk (OTCPK:AMKBY) (OTCPK:AMKAF) is pushing to “accelerate becoming an integrated provider of logistics, connecting, and simplifying our customers’ supply chains,” while MSC has built up its fleet to the point that it has overtaken Maersk in the number of ships it operates.
A.P. M?ller-Maersk (OTCPK:AMKBY) (OTCPK:AMKAF) recently named Vincent Clerc as its new CEO.
Article: seekingalpha.com
Business
U.S. Natural Gas Slides Below $3 for First Time in 19 Months
straga/iStock via Getty Images
U.S. natural gas futures fell below $3 for the first time since May 2021, trading as low as $2.992/MMBtu Wednesday before the front-month February contract (NG1:COM) settled at a new 52-week low, -5.8% to $3.067/MMBtu.
Since fears that suppliers couldn’t meet wintertime demand pushed U.S. natgas prices to a 14-year high of ~$10/MMBtu in August, U.S. and Europe have refilled their buffer inventories ahead of winter, and relatively warm temperatures in the Northern Hemisphere so far have held down demand for heating.
A longer than expected shutdown at the Freeport LNG terminal due to a fire in June has constrained gas exports and thus raised U.S. supplies, contributing to lower prices; the facility moved closer to restarting operations as the U.S. Coast Guard determined a hazard study addresses its requirements.
ETFs: (NYSEARCA:UNG), (UGAZF), (BOIL), (KOLD), (UNL), (FCG)
Gas-focused equities have fallen sharply during the past month: EQT (EQT) -8.6%, Range Resources (RRC) -5.1%, Antero Resources (AR) -14.2%, Southwestern Energy (SWN) -9.7%, Chesapeake Energy (CHK) -7.6%.
While natural gas prices may bottom soon, the U.S. Natural Gas ETF (UNG) is “likely a poor bet today due to the immense ‘contango decay’ embedded in the futures curve,” Harrison Schwartz writes in an analysis posted recently on Seeking Alpha.
Source Here: seekingalpha.com
Business
Sens. Warren, Welch Urge Moderna to Reconsider COVID-19 Shot Price Increase
Drew Angerer/Getty Images News
Democratic Sens. Elizabeth Warren (Mass.) and Peter Welch (Vt.) are asking Moderna (NASDAQ:MRNA) CEO Stephane Bancel to reconsider a price hike for COVID-19 vaccines once they become available through the commercial market.
Moderna (MRNA), like rival Pfizer (PFE), has said it plans to hike the price of its COVID shot to between $110 and $130 per dose, far higher than what the federal government has been paying for them.
“Moderna’s (MRNA) price hikes, aside from threatening public health, also raise questions about how Pfizer’s (PFE) similar announcement of vaccine price hikes in October 2022 may have influenced Moderna’s (MRNA) decision-making process regarding its vaccine prices,” the senators wrote.
The senators also noted that Moderna’s (MRNA) vaccine was developed through federally funded research.
The duo also ask Bancel several questions mostly dealing with revenue and profit expected this year from the vaccine.
COVID shots will become available through the commercial market — rather than for free due to federal government purchases — after the public health emergency for the virus is declared over.
Earlier in January, Sen. Bernie Sanders (I-Vt.) also sent a letter to Bancel.
Original Article: seekingalpha.com
-
Business9 months ago
BHP’s Quarterly Australian Iron Ore Shipments Slipped 8%
-
Business10 months ago
Muscular Dystrophy Drug Developer PepGen Files for $115M IPO
-
Business9 months ago
Robinhood Markets Q1 2022 Earnings Preview
-
Business9 months ago
Caesars Said to Seek Buyer for Flamingo Casino in Vegas for More Than $1B
-
Business9 months ago
Peru Declares Emergency in Bid to Restore Southern Copper’s Cuajone Mine
-
Business9 months ago
Gaming and Leisure Properties Q1 2022 Earnings Preview
-
Business9 months ago
Exxon Declares Force Majeure at Russia’s Sakhalin-1 Project
-
Business9 months ago
Buffett’s Berkshire Hathaway Buys Another 5.9M Occidental Shares